Court rejects Ryanair’s bid to delay operations chief’s easyJet move
December 23, 2019Bombardier’s new Global business jets get U.S. FAA certification
December 23, 2019Roche dives deeper into gene therapy with $1.15 billion Sarepta licensing deal
at
Roche Holding AG made its second major gene therapy deal in a year on Monday, spending $1.15 billion to obtain the rights to Sarepta Therapeutics Inc’s investigational drug to treat duchenne muscular dystrophy (DMD) outside the United States.
Powered by WPeMatico
